Explore evidence-based articles, clinical studies, and breakthrough discoveries in pharmacology
Explore the revolutionary bifunctional siRNA therapy that simultaneously targets TGF-β1 and activates RIG-I to combat pancreatic cancer's immunosuppressive defenses.